SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (1995)10/2/1997 10:45:00 AM
From: sam   of 6136
 
Henry: Just out of curiousity, what does LGND have in the pipeline to treat HIV? You posted an article on the LGND thread that suggests that RU486 may help fight HIV. And that that is good news for LGND. What are the implications of this drug on PI's currently on the market (like nelph). Will RU486 also develope resistance strains that will ultimately lead to a failure rate of 100%? Is there a any possibility it will lead to an AIDS cure? Or is this just more irrational exuberance by AIDS researchers? Your guidance here will be most appreciated. Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext